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 Purpose: To quantify the effect of sublingual isosorbide dinitrate 
(ISDN) administration on coronary magnetic resonance 
(MR) imaging.
 Materials and 
Methods: 
Written informed consent was obtained from all partici-
pants, and the HIPAA-compliant protocol was approved by 
the Institutional Review Board. Coronary MR imaging was 
performed at 1.5 T before and after administration of ISDN 
(2.5 or 5 mg) in 25 healthy adult volunteers (mean age, 23 
years  6 4; nine men, 16 women) with three-dimensional tar-
geted ( n = 20, randomized into four groups) or whole-heart 
( n = 5) acquisitions with gradient-recalled echo (GRE) or 
balanced steady-state free precession (SSFP) sequences. 
Image quality was assessed by two cardiologists on a four-
point scale. Signal-to-noise ratio (SNR), vessel diameter, 
and vessel sharpness were characterized. A linear mixed-
effects model was used for data analysis. A  P value of 
less than .05 was considered to indicate a signifi cant 
difference.
 Results: The maximum SNR enhancement with 5 mg of ISDN 
(GRE: 22.0%  6 10.7%; SSFP: 20.1%  6 6.0%) was similar 
( P  . .05) to that with 2.5 mg (GRE: 21.9%  6 5.4%; SSFP: 
19.1%  6 3.0%). However, the time to maximum SNR en-
hancement for the 5-mg dose (15.5 minutes  6 6.0) was 
earlier ( P  , .01) than that for 2.5 mg (23.5 minutes  6 6.7). 
The increase in vessel diameter with 5 mg of ISDN was 
greater than that with 2.5 mg ( P  , .05 for both GRE and 
SSFP sequences). The coronary images were sharper af-
ter ISDN administration ( P  , .03). Subjective image qual-
ity score signifi cantly improved after ISDN administration 
for GRE images ( P  , .05 for both doses) but was similar 
for SSFP images ( P = .24 for 2.5 mg;  P = .27 for 5 mg). 
Whole-heart coronary SNR was improved about 10% af-
ter ISDN administration ( P  , .05).
 Conclusion: Sublingual ISDN improves coronary MR imaging SNR. 
Practitioners need to consider the dose and temporal ef-
fects of ISDN when performing coronary MR imaging.
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not been studied. Accordingly, we sought 
to investigate the effect of sublingual 
ISDN in 3D coronary MR imaging on 
objective measures of coronary blood 
SNR, vessel diameter, and vessel sharp-
ness and overall subjective image quality 
as functions of time, dose, and imaging 
sequence. 
 Materials and Methods 
 Coronary MR imaging was performed in 
healthy adult volunteers before and after 
ISDN administration. Written informed 
consent was obtained from all partici-
pants, and the Health Insurance Porta-
bility and Accountability Act–compliant 
protocol was approved by our Institu-
tional Review Board. All volunteers were 
imaged with a 1.5-T magnet (Achieva; 
Philips Healthcare, Best, the Netherlands) 
with a 32-channel cardiac array coil (In-
vivo, Gainesville, Fla) for which an elec-
tronic signal combiner was used to form 
a 16-channel signal (eight anterior and 
eight posterior) from the 32-channel coil 
array or with a fi ve-channel synergy coil 
(Philips Healthcare). In each volunteer, 
the same coil was used for all studies. 
coronary artery MR imaging sequences 
that have been typically used are gradient-
recalled echo (GRE) and balanced steady-
state free precession (SSFP) ( 3,6 ). 
Owing to their higher SNR and blood-
myocardium contrast compared with 
GRE sequences, SSFP sequences are 
widely used in 3D coronary artery MR 
imaging at 1.5 T ( 3,17 ). However, GRE 
sequences are more frequently used at 
higher fi eld strengths because of the 
sensitivity of SSFP sequences to B 0 in-
homogeneity ( 4,9 ). Similar accuracy for 
the diagnosis of coronary artery disease 
has been reported ( 19,20 ) between 
these two techniques. 
 Despite the advantages in SNR and 
volumetric coverage compared with two-
dimensional techniques, 3D techniques 
suffer from infl ow saturation of coronary 
blood signal ( 21 ). In two-dimensional 
imaging, infl owing “fresh” spins provide 
blood signal enhancement. This effect 
is reduced in 3D imaging because the 
infl owing spins experience more radio-
frequency pulses while within the im-
aging volume and, consequently, the 
blood signal is saturated, although this 
infl ow saturation effect is more complex 
in SSFP imaging owing to its fully refo-
cused gradients and steady state in both 
longitudinal and transverse magnetiza-
tion. Therefore, an increase in coronary 
blood fl ow induced by vasodilators may 
be exploited to reduce the infl ow satura-
tion and improve SNR ( 22 ). 
 Vasodilators, such as isosorbide 
dinitrate (ISDN) and nitroglycerin, en-
hance coronary artery blood fl ow by 
providing exogenous nitric oxide that 
leads to relaxation of smooth muscle cells 
and, hence, vasodilation ( 23 ). The use 
of ISDN for coronary MR imaging was 
fi rst reported in a multicenter trial ( 24 ). 
In that study, sublingual ISDN (2.5 mg) 
was administered prior to imaging with 
a free-breathing targeted thin-slab 3D 
GRE sequence, but, to our knowledge, 
the effect of ISDN and its timing have 
 Despite substantial progress in the past decade, coronary artery mag-netic resonance (MR) imaging 
still faces multiple challenges owing to 
the relatively small diameter, tortuous 
nature, and nearly constant motion of 
the vessels. The high spatial resolution 
required to image stenoses in the coro-
nary arteries makes coronary MR imag-
ing a signal-to-noise ratio (SNR)-limited 
application. Recent technical develop-
ment of new sequences ( 1–3 ), contrast 
generation mechanisms ( 4–8 ), and 3.0-T 
coronary MR imaging ( 2,4,9–11 ) has 
enabled improvements in SNR and im-
age contrast. An increase in SNR can 
generally be used to improve resolution 
or to reduce respiratory and cardiac mo-
tion artifacts by shortening acquisition 
time. 
 In the past decade, three-dimensional 
(3D) coronary artery MR imaging 
sequences have largely replaced two-
dimensional approaches because they 
provide volumetric coverage of the 
coronary arteries with high SNR ( 12 ). 
In the 3D targeted approach, separate 
thin (  30-mm) 3D slabs are prescribed 
along major axes of the coronary arter-
ies, and imaging is performed during 
free-breathing with a navigator echo 
to compensate for respiratory motion 
( 6,13,14 ). As an alternative, large 3D 
slab coronary MR imaging methods 
provide whole-heart coverage in a sin-
gle volume ( 15–18 ). Two types of 3D 
 Implication for Patient Care 
 Practitioners should consider the  n
potential benefi ts of sublingual 
ISDN administration when per-
forming coronary MR imaging. 
 Advances in Knowledge 
 We demonstrate that sublingual  n
isosorbide dinitrate (ISDN) 
administration improves coro-
nary MR imaging signal-to-noise 
ratios (SNRs) by 20% for thin-
slab targeted acquisitions and by 
10% for thick-slab whole-heart 
acquisitions, increases vessel 
diameter by 10%–15% (2.5-mg 
dose) or 20%–25% (5-mg dose), 
and improves image quality for 
gradient-recalled echo coronary 
MR imaging. 
 The maximum SNR enhancement  n
occurs from 15 (5-mg dose) to 
25 (2.5-mg dose) minutes after 
sublingual ISDN administration. 
 Published online 
 10.1148/radiol.09090483 
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in the region of interest was used as 
the signal intensity of the coronary ar-
tery blood. SNR was calculated as the 
mean signal intensity from the coronary 
blood divided by the standard deviation 
of pixel values in the region of interest 
outside of the chest well (ie, noise). For 
consistency, the same regions of inter-
est were used in all image sets for each 
patient, unless motion was detected 
between sets. The change in SNR was 
calculated according to the following 
equation:  D SNR = (SNR ISDN  2 SNR pre )/
SNR pre , where SNR ISDN is the SNR after 
administration of ISDN and SNR pre is 
the baseline SNR. 
 Because coronary MR imaging was 
performed fi ve times after administra-
tion of ISDN, imaging was performed 
only in a targeted 3D slab along the 
long axis of the RCA. The left coronary 
artery (LCA) was partially visible in the 
RCA images. To study the effect of ISDN 
administration on the LCA system, the 
SNR in the proximal LCA was also mea-
sured by using a similar method. 
 Vessel diameter.— The raw data 
were imported into a 3D coronary im-
age analysis tool (SoapBubble; Philips 
Healthcare) for quantitative measure-
ment and visualization ( 26 ). The coro-
nary artery was identifi ed by using the 
vessel tracking tool, and the mean ves-
sel diameter in the proximal 4 cm of the 
RCA was automatically calculated. The 
change in vessel diameter was calculated 
as:  D D = ( D ISDN  2  D pre )/ D pre , where  D ISDN 
is the mean vessel diameter after admin-
istration of ISDN and  D pre is the mean 
vessel diameter at baseline. 
 Vessel sharpness.— The SoapBubble 
tool ( 26 ) was used to quantitatively 
evaluate the vessel defi nition with a De-
riche algorithm ( 27 ). Vessel sharpness 
scores were calculated for both sides 
of the vessel, and fi nal sharpness was 
defi ned as the mean. Higher sharpness 
scores indicate sharper vessel borders. 
The percentage change in vessel sharp-
ness was calculated for each volunteer. 
 Whole-Heart Study 
 To study the effect of ISDN on thick-slab 
(10–12-cm) whole-heart SSFP images, 
fi ve additional healthy volunteers (one 
man [24 years] and four women [mean 
baseline imaging, and it was repeated 
fi ve times with no time gap to study 
the time-course effect of ISDN. The 
initiation time for imaging session with 
respect to ISDN administration was re-
corded (P.H.). For groups C and D, a 
free-breathing 3D electrocardiographi-
cally gated GRE sequence was used 
(7.7/2.2; fi eld of view, 270  3 270  3 
30 mm; fl ip angle, 30°; spatial resolu-
tion, 0.7  3 1  3 1.5 mm reconstructed 
to 0.52  3 0.52  3 0.75 mm). The pa-
rameters for SSFP imaging in groups A 
and B were as follows: 4.6/2.3; fi eld of 
view, 270  3 270  3 30 mm; fl ip angle, 
90°; and spatial resolution, 1  3 1  3 
1.5 mm reconstructed to 0.52  3 0.52 
 3 0.75 mm.  A half- a preparation pulse 
was used with the SSFP imaging. For all 
groups, a two-dimensional spiral naviga-
tor echo, positioned on the right hemid-
iaphragm ( 6 ), was used for respiratory 
motion gating and tracking with a gating 
window of 5 mm. A T2 magnetization 
preparation sequence (echo time, 50 
milliseconds) was also used to enhance 
blood-myocardium contrast ( 6,8 ). To 
obtain a more accurate SNR measure-
ment, no parallel imaging was used for 
coronary MR imaging acquisitions. 
 Qualitative image measurements.— 
Qualitative analyses were performed by 
two cardiologists (W.J.M. and M.L.C., 
with more than 10 and 15 years experi-
ence with cardiac MR imaging, respec-
tively) who were blinded to subject, ISDN 
dose, and sequence information. The 
images were randomized before presen-
tation to the cardiologists, who graded the 
images during a single reading session. 
A four-point scale ( 24 ) was used to eval-
uate the diagnostic value of the images: 
1 = poor, 2 = fair, 3 = good, and 4 = very 
good or excellent. For each image, sep-
arate scores were given for the proximal, 
middle, and distal segments of the RCA. 
 SNR measurements.— SNR was 
measured (P.H.) with the image analy-
sis software on the imager console. To 
quantify SNR, a region of interest was 
selected outside of the chest wall, and 
the standard deviation of its pixel val-
ues was used as the noise. A polygonal 
region of interest was carefully drawn 
in the proximal RCA after four-fold 
magnifi cation. The mean pixel value 
Blood pressure was noninvasively moni-
tored every 15 minutes by using an au-
tomated sphygmomanometer (Dinamap; 
GE Healthcare, Milwaukee, Wis) with a 
cuff on the volunteer’s calf. Volunteers 
with systolic pressure lower than 100 mm 
Hg were given no more than 2.5 mg 
of ISDN to minimize the possibility of 
symptomatic hypotension. 
 Targeted 3D Study 
 A total of 20 adult clinically healthy vol-
unteers (eight men [mean age, 24 years 
 6 3 {standard deviation}] and 12 women 
[mean age, 23 years  6 3]) without con-
traindications to MR imaging were in-
cluded in our study. Scout images were 
acquired with an SSFP sequence with 
3.12  3 3.12–mm in-plane resolution 
and 10-mm section thickness. A refer-
ence image set was acquired by using 
the body and phased-array coils so 
that each individual coil sensitivity map 
could be calculated ( 25 ). This was fol-
lowed by an image set acquired with an 
axial breath-hold cine SSFP sequence 
(repetition time msec/echo time msec, 
3.7/1.85; temporal resolution, 48 mil-
liseconds; spatial resolution, 1.2  3 1.2 
mm; acceleration rate, two) to visually 
identify (P.H., with 5 years experience) 
 the quiescent period of the right coro-
nary artery (RCA). The corresponding 
trigger delay was used in later sequences. 
A low-resolution coronary survey 3D 
volume was then acquired for localiza-
tion and assignment of the appropriate 
imaging slab orientation ( 6 ). 
 Volunteers were randomly divided 
into four groups (A, B, C, and D), with 
fi ve in each group, to investigate the ef-
fects of the imaging sequence and the 
ISDN dose. In groups A and B, RCA 
images were acquired with a 3D tar-
geted thin-slab SSFP sequence with 
2.5- or 5-mg doses of ISDN, respec-
tively. In groups C and D, images were 
acquired with a GRE sequence with 2.5 
or 5 mg of ISDN, respectively. For each 
group, baseline coronary imaging (GRE 
or SSFP) was performed after assign-
ment of slab orientation, followed by 
sublingual administration of ISDN (2.5 
or 5 mg). Imaging was started imme-
diately after ISDN administration with 
the same sequence that was used for 
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did not change signifi cantly (68 beats 
per minute  6 10 vs 70 beats per min-
utes  6 11). 
 Targeted 3D Study 
 Image quality.— Figure 1 shows exam-
ples of RCA MR images obtained with a 
GRE sequence with two different doses 
of ISDN. All images are labeled with 
scan initiation time after ISDN adminis-
tration. Corresponding images with an 
SSFP sequence in two other volunteers 
are shown in  Figure 2 . Vasodilation and 
image quality improvement versus base-
line images can be observed for both 
ISDN doses with both GRE and SSFP 
sequences. In addition to improving the 
overall image quality, the SNR gain and 
vasodilation from ISDN administration 
also enabled better visualization of the 
distal segments of the coronary arteries 
( Figs 1,  2 ). 
 Subjective image quality scores im-
proved signifi cantly for GRE MR images 
after ISDN administration ( P  , .05 for 
both 2.5 [group C] and 5 [group D] mg), 
but the changes were not signifi cant for 
SSFP MR images ( P = .24 for 2.5 mg 
[group A] and  P = .27 for 5 mg [group B]). 
The mean difference between scores 
before and those after administration of 
ISDN, adjusted for reader and coronary 
segment, was 0.32 (95% confi dence 
interval [CI]: 0.07, 0.57) for group C, 
(SAS, version 8.01; SAS Institute, Cary, 
NC) was used for all statistical analy-
ses. Owing to the repeated-measures 
design of our study (one acquisition 
before and fi ve after administration 
of ISDN), the correlation induced by 
within-subject variance had to be taken 
into account in the analysis. We used 
a linear mixed-effects model with com-
pound symmetry variance-covariance 
structure for the error matrix and 
linear contrasts ( 29 ) for comparing 
the SNR, vessel diameter, vessel sharp-
ness, and qualitative image scores be-
fore and after ISDN administration. 
The model was adjusted for reader and 
coronary segment in the qualitative im-
age score analysis. A two-tailed  P value 
less than .05 was considered to indicate 
signifi cance. 
 Results 
 All volunteers completed the study 
without complications. There was no 
signifi cant difference between the mean 
ages of male and female volunteers. 
One volunteer did not receive the 5-mg 
ISDN dose because of low blood pres-
sure. Mean blood pressure decreased 
signifi cantly after ISDN administration 
(systolic: 129 mm Hg  6 16 vs 104 mm 
Hg  6 8; diastolic: 58 mm Hg  6 7 vs 50 
mm Hg  6 7; both  P  , .05). Heart rate 
age, 22 years  6 3]) were recruited and 
underwent whole-heart coronary MR 
imaging before and twice after admin-
istration of 5 mg of ISDN. Images were 
acquired with a free-breathing SSFP se-
quence (4.8/2.4; fl ip angle, 90°, fi eld of 
view, 300  3 300  3 120 mm; isotropic 
spatial resolution, 1.3  3 1.3  3 1.3 mm 
reconstructed to 0.65  3 0.65  3 0.65 
mm with zero-padding) with T2 mag-
netization preparation (echo time, 50 
milliseconds) and spectrally selective 
fat saturation. SNR and vessel diameter 
changes in the proximal RCA and LCA 
were measured with the aforemen-
tioned methods. Because parallel imag-
ing with an acceleration factor of two 
was used in the whole-heart study to re-
duce acquisition duration, each acquisi-
tion was followed by a noise acquisition 
with identical parameters but with ra-
diofrequency excitation pulses disabled. 
The region of interest used in coronary 
artery signal intensity measurements 
was copied to the noise acquisition im-
age to compensate for spatially varying 
g factor ( 28 ). SNR was calculated as the 
mean signal intensity from the coronary 
blood divided by the standard deviation 
of this measured noise. 
 Statistical Analysis 
 All measurements are presented as the 
mean  6 1 standard deviation. Software 
 Figure 1 
  
 Figure 1: Multiplanar reconstruction RCA 3D free-breathing GRE MR images (7.7/2.2; fl ip angle, 30°) acquired before  (PRE) and after 
administration of (top) 2.5 or (bottom) 5 mg of ISDN in two healthy volunteers. Time after ISDN administration appears on upper left of images. 
Increased vessel diameter and RCA signal enhancement were observed with both doses, especially distally (arrowheads).  ∗ = image quality 
score, # = SNR,   = vessel sharpness score. 
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than for the 2.5-mg dose (15.5 minutes 
 6 6.0 vs 23.5 minutes  6 6.7 minutes; 
 P  , .01). The individual SNR data are 
summarized in  Table 1 . 
 Vessel diameter.— Figure 4 shows 
the time course of coronary vessel di-
ameter increase during the fi rst 30 min-
utes after ISDN administration. Vessel 
diameter was signifi cantly increased 
after ISDN administration ( P  , .02). 
Vasodilation with 5 mg (GRE: 23.7% 
 6 8.9%; SSFP: 26.5%  6 10.4%) was 
greater ( P  , .03) than that with 2.5 mg 
(GRE: 14.7%  6 3.6%; SSFP: 16.3%  6 
6.8%). The vasodilations measured from 
GRE and SSFP imagers were similar 
( P  . .05). The individual vessel diam-
eter data are summarized in  Table 2 . 
 Vessel sharpness.— Figure 5 shows 
the time course of vessel sharpness 
changes. The images from all four groups 
were sharper after ISDN administration 
( P  , .03). The maximum vessel sharp-
ness increase occurred 16–23 min-
utes after ISDN administration ( P  , .05 
for all four groups). There was a trend 
for increased sharpness with the SSFP 
sequence as opposed to the GRE se-
quence ( P = .057). The individual ves-
sel sharpness data are summarized in 
 Table 3 . 
 Whole-Heart Study 
 The imaging initiation times for whole-
heart acquisitions were 0.2 minutes  6 0.1 
The maximum SNR enhancement in the 
RCA with 5 mg of ISDN (GRE: 22.0%  6 
10.7%; SSFP 20.1%  6 6.0%) was simi-
lar ( P  . .05) to that with 2.5 mg (GRE: 
21.9%  6 5.4%; SSFP: 19.1%  6 3.0%). 
The maximum SNR enhancement in 
the proximal LCA with 5 mg of ISDN 
(GRE: 17.3%  6 12.6%; SSFP: 23.9% 
 6 41.3%) was similar ( P  . .05) to that 
with 2.5 mg (GRE: 17.2%  6 13.6%; 
SSFP: 20.5%  6 32.3%). The imaging 
initiation time for maximum SNR en-
hancement for both the RCA and proxi-
mal LCA was shorter for the 5-mg dose 
0.33 (95% CI: 0.05, 0.61) for group D, 
0.20 (95% CI:  2 0.08, 0.48) for group 
A, and 0.07 (95% CI:  2 0.4, 0.54) for 
group B. The effects of vessel segment 
on improvement of image quality score 
after ISDN administration were not sig-
nifi cant ( P = .16 for group C,  P = .43 for 
group D,  P = .16 for group A, and  P = .97 
for group B). 
 SNR measurements.— Figure 3 shows 
the percentage change in coronary 
blood SNR after ISDN administration. 
Coronary SNR signifi cantly improved 
after ISDN administration ( P  , .05). 
 Figure 2 
  
 Figure 2: RCA 3D free-breathing SSFP MR images (4.6/2.3; fl ip angle, 90°) acquired before  (PRE) and after administration of (top) 2.5 or 
(bottom) 5 mg of ISDN in two healthy volunteers. Time after ISDN administration appears on upper left of images. Improved RCA vasodilation 
and signal enhancement (arrows) were observed on all images obtained after ISDN administration. Owing to enhanced SNR, distal segments 
were visualized better with ISDN (arrowheads).  ∗ = image quality score, # = SNR,   = vessel sharpness score. 
 Figure 3 
  
 Figure 3: Bar graph  shows time course of SNR enhancement change after ISDN administration in 
four groups studied. Maximum (  20%) increase in SNR was observed on image sets initiated at 
15 (5 mg) and 25 (2.5 mg) minutes after ISDN administration. Individual imaging initiation times 
were averaged for each of fi ve sets. Error bars = standard deviations. 
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and 17 minutes  6 5 after ISDN admi-
nistration. Coronary SNR improved 
during the fi rst whole-heart acquisition 
after ISDN administration (RCA: 11.7% 
 6 8.5%; LCA: 6.9%  6 2.1%; both 
 P  , .05), but only the SNR in the LCA 
signifi cantly improved during the sec-
ond acquisition (RCA: 1.8%  6 4.4%, 
 P  . .05; LCA: 7.5%  6 4.2%,  P  , .05). 
Vessel diameter increased signifi cantly 
during both the fi rst (RCA: 13.1%  6 
2.0%; LCA: 11.7%  6 3.1%; both  P  , 
.05) and second (RCA: 17.7%  6 7.9%; 
LCA: 19.3%  6 4.2%; both  P  , .05) 
whole-heart acquisitions. 
 Discussion 
 We have demonstrated that SNR, vessel 
sharpness, and image quality improve 
owing to infl ow enhancement on 3D tar-
geted coronary MR images obtained with 
both GRE and SSFP sequences and that 
SNR increases on whole-heart SSFP MR 
images. Our data suggest that maximum 
SNR enhancement for both sequences 
is similar for both 2.5- and 5-mg ISDN 
doses. However, with the 5-mg dose, 
maximum SNR enhancement occurred 
earlier, and vasodilation was greater. 
Commonly, sublingual ISDN is admin-
istered followed immediately by initia-
tion of coronary MR imaging ( 24 ). Our 
data suggest that coronary MR imaging 
should be performed 15 minutes after 
administration of a 5-mg dose of ISDN. 
 Researchers in previous studies 
have evaluated the vasodilation effect of 
shorter acting nitrates. Terashima et al 
( 22 ) reported use of a two-dimensional 
multisection spiral coronary MR imaging 
sequence to evaluate the vasodilation 
effect of sublingual nitroglycerin and 
found that coronary cross-sectional area 
increased 23%, with an SNR increase 
of 31%. The difference in SNR increase 
between their study and our data may 
be owing to the different techniques 
and vasodilators used. Simonetti et al 
( 30 ) investigated the dose- and time-
related response to intracoronary ISDN 
by using conventional coronary angiog-
raphy. They found a coronary diameter 
increase of 18%–26% in response to 
administration of intracoronary ISDN, 
which is similar with our fi ndings. 
 Table 1 
Percentage Changes in Individual RCA SNRs after ISDN Administration 
Group and Subject First Acquisition Second Acquisition Third Acquisition Fourth Acquisition Fifth Acquisition 
Group C * 8.3  6 7.0 11.1  6 5.2 16.5  6 6.5 21.9  6 5.4 15.3  6 2.9
 1 2.7 5.1 9.1 14.9 13.1
 2 2.8 8.1 9.8 28.2 17.6
 3 11.0 10.5 22.0 26.1 15.7
 4 19.2 18.9 20.2 19.0 11.6
 5 5.7 13.1 21.7 21.4 18.5
Group D * 5.8  6 8.8 17.3  6 10.8 22.0  6 10.7 12.3  6 11.6 9.0  6 9.3
 6  2 6.9 18.7 33.7 16.7  2 0.3
 7 3.8 30.7 14.0 3.9 8.5
 8 15.5 24.1 32.4 29.5 24.6
 9 13.0 5.5 9.9  2 0.1 6.2
 10 3.6 7.2 20.0 11.6 6.0
Group A * 5.0  6 4.6 8.8  6 3.6 16.6  6 2.7 19.1  6 3.0 10.5  6 14.8
 11 3.6 4.0 19.6 17.0 16.0
 12 6.4 6.7 14.6 18.8  2 7.5
 13 12.3 12.2 13.0 24.2 30.5
 14 2.0 12.2 17.5 19.0 14.0
 15 0.7 8.7 18.2 16.9  2 0.2
Group B * 7.3  6 5.6 16.9  6 7.0 20.1  6 7.5 9.9  6 9.8 8.4  6 10.6
 16 5.0 17.5 27.5 22.6 25.0
 17 17.0 26.1 19.5 12.9 9.2
 18 3.5 8.8 10.5 0.0  2 1.7
 19 3.8 11.5 15.4 0.1  2 0.1
 20 7.5 20.6 27.5 14.2 9.4
Note.—Data are percentages. Group A = SSFP sequence with 2.5 mg of ISDN, group B = SSFP sequence with 5 mg of ISDN, 
group C = GRE sequence with 2.5 mg of ISDN, group D = GRE sequence with 5 mg of ISDN.
* Data are means  6 standard deviations.
 Figure 4 
  
 Figure 4: Bar graph shows time course of coronary vessel diameter change after ISDN 
administration in four groups studied. Signifi cant vasodilation was observed immediately 
after ISDN administration and persisted throughout time course ( P  , .02). Vasodilation was 
greater ( P  , .03) with 5-mg than with 2.5-mg ISDN dose. Vasodilation between GRE and SSFP 
sequences was similar. Error bars = standard deviations. 
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 We selected ISDN dose on the ba-
sis of several factors. First, 2.5–5 mg is 
commonly used for anginal prophylaxis 
prior to physical activity, indicating that 
physiologically meaningful coronary vaso-
dilation can be achieved with this dose. 
Second, although all healthy subjects 
completed our study without compli-
cations from ISDN administration, the 
potential side effects of ISDN (eg, blood 
pressure drop) had to be considered. 
We used relatively low doses to mini-
mize possible side effects. Third, as 
ISDN is readily available in 2.5- and 
5-mg doses, we elected to use these 
doses for convenience, subject to the 
preceding two concerns. 
 We have shown that ISDN admin-
istration signifi cantly improves quality 
scores for images obtained with a GRE 
sequence but not for those obtained 
with an SSFP sequence, despite simi-
lar SNR improvements. A potential ex-
planation is that SSFP coronary artery 
MR images have higher baseline SNR 
and image quality than do GRE MR im-
ages ( 20 ). For GRE images, the same 
quality improvement after ISDN ad-
ministration may be more conspicuous 
owing to lower baseline image quality 
and SNR. 
 The tradeoff between spatial resolu-
tion and acquisition time to maintain a 
suffi cient SNR is a major limiting fac-
tor in coronary MR imaging. Currently, 
submillimeter resolution is commonly 
achieved in coronary MR imaging, 
which is adequate for visualizing the 
course of coronary arteries. However, 
coronary MR imaging has inferior spa-
tial resolution compared with coronary 
computed tomographic angiography 
( 31 ), for which vasodilators are com-
monly used. The signifi cant SNR gain 
we found by using ISDN may enable 
higher spatial resolution and shorter 
imaging time with parallel imaging. The 
recent progress of coronary MR imag-
ing at 3.0 T ( 4,10,11,32 ) has the poten-
tial to improve SNR and spatial resolu-
tion. We expect ISDN administration to 
provide additional SNR enhancement 
for coronary MR imaging at 3.0 T. 
 Contrast agent–enhanced coronary 
MR imaging has been reported as a 
promising alternative to unenhanced 
 Table 2 
 Percentage Changes in Individual RCA Vessel Diameters after ISDN Administration 
Group and Subject First Acquisition Second Acquisition Third Acquisition Fourth Acquisition Fifth Acquisition 
Group C * 7.1  6 8.3 11.6  6 7.6 12.9  6 6.9 13.5  6 8.2 14.7  6 3.6
 1 11.9 18.7 23.1 22.6 12.9
 2 11.9 18.8 13.0 11.8 13.8
 3 10.6 11.0 14.4 20.0 21.1
 4  2 7.6 0.6 4.2 2.0 13.2
 5 8.7 8.8 9.9 11.0 12.6
Group D * 15.7  6 8.7 21.6  6 8.7 20.3  6 10.0 23.7  6 9.0 18.4  6 11.9
 6 16.6 29.0 18.4 26.5 21.5
 7 2.5 11.9 12.3 14.7 2.0
 8 24.6 30.7 33.8 35.7 32.8
 9 13.1 13.4 9.8 14.7 11.2
 10 22.0 23.3 26.9 26.9 24.3
Group A * 7.3  6 4.8 11.7  6 9.1 14.4  6 4.2 13.9  6 4.2 16.3  6 6.8
 11 11.6 22.0 18.5 16.5 24.3
 12 11.6 16.0 14.0 12.8 10.6
 13 4.7  2 2.6 7.6 7.2 9.4
 14 0.5 10.7 17.2 17.7 14.8
 15 8.2 12.4 14.6 15.5 22.4
Group B * 12.2  6 8.9 19.4  6 8.8 21.3  6 10.6 25.1  6 10.7 22.1  6 11.8
 16 28.0 34.6 35.4 36.7 35.6
 17 7.3 15.9 18.7 19.8 22.6
 18 7.8 13.2 9.7 12.8 4.8
 19 9.7 14.2 14.0 20.1 17.7
 20 8.2 19.0 28.8 36.1 29.9
Note.—Data are percentages. Group A = SSFP sequence with 2.5 mg of ISDN, group B = SSFP sequence with 5 mg of ISDN, 
group C = GRE sequence with 2.5 mg of ISDN, group D = GRE sequence with 5 mg of ISDN.
* Data are means  6 standard deviations.
 Figure 5 
  
 Figure 5: Bar graph shows time course of coronary vessel sharpness score change after 
ISDN administration in four groups studied. Coronary images were sharper after ISDN adminis-
tration ( P  , .03). Error bars = standard deviations. 
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at different times after ISDN admin-
istration. However, the goal of our 
time-course study was to obtain an ap-
proximate time of maximum benefi ts. 
The averaging appears to be suffi cient 
to achieve the goal, given that it was 
impractical to image each individual 
at exactly the same time after ISDN 
administration. 
 Our study had limitations. Only young 
healthy adult volunteers were studied. 
The physiology of blood fl ow in the cor-
onary arteries may be different in older 
subjects and in patients with coronary 
artery disease. The number of volun-
teers in our study (fi ve in each group) 
was relatively small. Further research 
is needed to study the effect of sublin-
gual ISDN on coronary MR imaging in a 
larger patient population. 
 In conclusion, sublingual ISDN im-
proves the 3D coronary MR imaging 
SNR by 20% for targeted acquisitions 
and by 10% for whole-heart acquisi-
tions. Increases in vessel diameter are 
dose dependent. Maximum SNR en-
hancement occurs from 15 to 25 min-
utes after ISDN administration for 5- 
and 2.5-mg doses, respectively. Cardiac 
MR practitioners should consider these 
dose and temporal effects of ISDN when 
performing coronary MR imaging. 
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vide signifi cant SNR improvements in 
contrast-enhanced coronary MR imag-
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tained vasodilation with ISDN may be 
useful in contrast-enhanced coronary 
MR imaging, especially in coronary im-
aging methods with slow infusion of the 
contrast agent ( 4 ). 
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the thin-slab targeted approach. Al-
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